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Cohort studies of excess body weight and risk of liver cancer were identified for a meta-analysis by searching MEDLINE and EMBASE
databases from 1966 to June 2007 and the reference lists of retrieved articles. Results from individual studies were combined using a
random-effects model. We identified 11 cohort studies, of which seven on overweight (with a total of 5037 cases) and 10 on obesity
(with 6042 cases) were suitable for meta-analysis. Compared with persons of normal weight, the summary relative risks of liver
cancer were 1.17 (95% confidence interval (CI): 1.02–1.34) for those who were overweight and 1.89 (95% CI: 1.51–2.36) for those
who were obese. This meta-analysis finds that excess body weight is associated with an increased risk of liver cancer.
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Although relatively rare in the United States and other developed
countries, liver cancer is the third most common cause of
death from cancer worldwide (Parkin et al, 2005). It is rarely
detected early and is often fatal within a few months of diagnosis.
The 5-year survival rate is only about 6–11% (Coleman et al,
2003; Ries et al, 2006). The age-adjusted incidence and mortality
rates of liver cancer have been increasing rapidly in the
United States since the mid-1980s (Ries et al, 2006). While
approximately half of this increase can be attributable to hepatitis
C virus infection, a minimal or no increase has been related to
hepatitis B virus and alcoholic liver disease (El-Serag and Mason,
2000; Hassan et al, 2002). Given that about half of the increase
in liver cancer incidence is not related to hepatitis, the major
risk factor in a significant proportion of the cases has yet to be
identified.
Coinciding with the rising incidence of liver cancer, the
prevalence of obesity has been increasing markedly over the past
two decades worldwide (Larsson and Wolk, 2006). Obesity has
been recognised as a risk factor for several malignancies, including
cancer of the breast (in premenopausal women), endometrium,
kidney (renal cell), colon, pancreas, gallbladder, and esophagus
(adenocarcinoma) (IARC, 2002; Larsson et al, 2007; Larsson and
Wolk, 2007). Accumulating epidemiologic evidence also indicates
that excess body weight may be a risk factor for liver cancer, but
the evidence has not been quantitatively summarised. We have
therefore quantitatively assessed the associations of overweight
and obesity with liver cancer risk in a meta-analysis of cohort
studies.
MATERIALS AND METHODS
Study selection
A literature search was conducted in the MEDLINE and EMBASE
databases for pertinent studies published in any language from
1966 to June 2007. We used the keywords ‘body mass index’, ‘BMI’,
or ‘obesity’ in combination with ‘hepatocellular carcinoma’, ‘liver
cancer’, or ‘liver neoplasm’. Moreover, we manually reviewed the
reference lists of retrieved articles to search for more studies.
Studies were included in the meta-analysis if they fulfilled the
following criteria: (1) cohort study in which liver cancer incidence
or mortality was an outcome; (2) the exposure of interest was
overweight and/or obesity defined by body mass index (BMI) (the
weight in kilograms divided by the square of height in meters); and
(3) relative risk estimates (rate ratio or standardized incidence
ratio) with corresponding 95% confidence intervals (CIs) were
reported.
Data extraction
For each study, the following information was extracted: first
author’s last name; publication year; country in which the study
was performed; sample size; method of assessing weight and
height; type of outcome (incidence or mortality); variables
adjusted for in the analysis; and the relative risks with 95% CIs
for overweight and obesity vs normal weight. From each study, we
extracted the most fully adjusted relative risks.
Statistical analysis
The relative risks and corresponding standard errors (derived
from the CIs) from individual studies were logarithmically
transformed to stabilize variances and normalize the distributions.
We calculated summary relative risks for overweight (defined as
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 2) and obesity (BMI X30kgm
 2) vs normal
weight (BMI 18.5–24.9kgm
 2). For two studies (Calle et al, 2003;
Kuriyama et al, 2005) that reported relative risks for two categories
of BMI that fell into the category representing overweight or
obesity, we pooled the relative risks and used the pooled estimate
in the meta-analysis. Study-specific relative risks were combined
using the DerSimonian and Laird random-effects model
(DerSimonian and Laird, 1986). Thus, each summary relative risk
was a weighted average of the study-specific relative risk, where the
weight for each study is the inverse of the sum of the within-study
variance for that study, and the between-study variance.
Statistical heterogeneity among studies was evaluated with the Q
and I
2 statistics (Higgins and Thompson, 2002). For the Q statistic,
statistical significance was set at Po0.1. We used funnel plots
(i.e. plots of study results against precision) to assess publication
bias, and tested the symmetry of the funnel plot using Egger’s test
(Egger et al, 1997).
Results are presented graphically, whereby squares represent
study-specific relative risks and diamonds represent summary
relative risks. The area of each square is proportional to the inverse
of the variance of the logarithm of the relative risk; 95% CIs for
individual studies are represented by horizontal lines and for the
summary estimates by the width of the diamonds. Statistical
analyses were performed with Stata, version 9.0 (StataCorp,
College Station, TX, USA).
Population attributable risk (PAR) for liver cancer was
estimated for individuals with excess body weight
(BMIX25kgm
 2) compared to those of normal weight
(BMIo25kgm
 2). The PAR describes the theoretic proportion
of cases that would be prevented if all individuals were moved into
the exposure level associated with the lowest risk for that factor.
The PAR (PAR%) was calculated as: PAR%¼(p [RR–1]/
[p (RR–1)þ1]) 100%, where p represents the prevalence in
the population and RR the relative risk. Prevalence data were
obtained from the National Health and Nutrition Examination
Survey that assessed the prevalence of overweight and obesity in a
representative sample of the US population (Ogden et al, 2006). In
that survey, 39.7% of the men were overweight and 31.1% were
obese. Among women, 28.6% were overweight and 33.2% were
obese. PARs were calculated for the overweight and obese
categories using the obtained summary relative risks, and then
summarized across the two categories for men and women
separately.
RESULTS
We identified 11 eligible cohort studies (Møller et al, 1994; Wolk
et al, 2001; Nair et al, 2002; Calle et al, 2003; Samanic et al, 2004,
2006; Batty et al, 2005; Kuriyama et al, 2005; Oh et al, 2005; Rapp
et al, 2005; N’Kontchou et al, 2006), of which 7 on overweight (with
a total of 5037 cases) (Calle et al, 2003; Batty et al, 2005; Kuriyama
et al, 2005; Oh et al, 2005; Rapp et al, 2005; N’Kontchou et al, 2006;
Samanic et al, 2006) and 10 on obesity (with a total of 6042 cases)
(Møller et al, 1994; Wolk et al, 2001; Nair et al, 2002; Calle et al,
2003; Samanic et al, 2004, 2006; Batty et al, 2005; Oh et al, 2005;
Rapp et al, 2005; N’Kontchou et al, 2006) were suitable for meta-
analysis. Characteristics of the studies are shown in Table 1. Seven
studies were conducted in Europe, two in the United States, and
two in Asia. Weight and height were measured in six studies and
self-reported in two studies; in three studies, obesity was defined
by a discharge diagnosis of obesity. The outcome was incidence
of liver cancer in all but two studies (Calle et al, 2003; Batty et al,
2005) in which the outcome was mortality from liver cancer. Two
studies were based on standardized incidence ratio (Møller et al,
1994; Wolk et al, 2001). Two studies consisted of patients with
cirrhosis (Nair et al, 2002; N’Kontchou et al, 2006).
Relative risks of liver cancer for overweight and obese
individuals compared to those of normal weight for individual
studies (separately for men and women wherever this data were
available) and all studies combined are shown in Figure 1. Meta-
analysis of all studies found that compared to individuals with
normal weight, those who were overweight or obese had a 17 and
89%, respectively, increased risk of liver cancer. There was
statistically significant heterogeneity among the results of indivi-
dual studies (Figure 1). The summary relative risk for obesity was
statistically significantly higher (P¼0.03) for men (RR: 2.42; 95%
CI: 1.83–3.20; n¼7 studies) than for women (RR: 1.67; 95% CI:
Table 1 Characteristics of cohort studies included in the meta-analysis
Study Country
No. of cases
(men/women) Study participants
Assessment of
exposure Adjustments
Møller et al (1994) Denmark 22/36 Men: 14531
Women: 29434
Discharge diagnosis of
obesity
Age
Wolk et al (2001) Sweden 15/13 Men: 8165
Women: 19964
Discharge diagnosis of
obesity
Age, calendar year
Nair et al (2002) USA 659
a Men and women: 19271
a Measured Age, sex, race, diabetes
Calle et al (2003) USA 620/345 Men: 404576
Women: 495477
Self-reported Age, race, education, marital status, smoking,
physical activity, aspirin use, estrogen-replacement
therapy (women), alcohol, dietary factors
Samanic et al (2004) USA 322 whites/38
blacks
White men: 3668486
Black men: 832214
Discharge diagnosis of
obesity
Age, calendar year
Kuriyama et al (2005) Japan 69/31 Men: 12485
Women: 15054
Self-reported Age, type of health insurance, smoking, intakes of
alcohol, meat, fish, fruits, vegetables, bean-paste
soup
b
Batty et al (2005) UK 51 Men: 18403 Measured Age, employment grade, marital status, physical
activity, smoking, other
c
Oh et al (2005) Korea 3347 Men: 781283 Measured Age, area of residence, family history of cancer,
smoking, exercise, alcohol
Rapp et al (2005) Austria 57 Men: 67447 Measured Age, occupational group, smoking
N’Kontchou et al (2006) France 220
a Men and women: 771
a Measured Age, sex, cirrhosis cause, diabetes
Samanic et al (2006) Sweden 297 Men: 362552 Measured Age, smoking
aPatients with cirrhosis.
bOdds ratios for women were further adjusted for age at menarche, age at end of first pregnancy, and menopausal status.
cOther factors adjusted for
include disease at entry, weight loss in the last year, height-adjusted FEV1, triceps skinfold thickness, blood pressure-lowering medication, blood pressure, plasma cholesterol,
glucose intolerance, and diabetes.
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bias on the funnel plot (data not shown) or by Egger’s test
(P¼0.31 for overweight and P¼0.21 for obesity).
In a sensitivity analysis excluding the two studies that consisted
of patients with cirrhosis (Nair et al, 2002; N’Kontchou et al, 2006),
the summary relative risks were 1.07 (95% CI: 1.01–1.15) for
overweight and 1.85 (95% CI: 1.44–2.37) for obesity. With
stratification by assessment of obesity, the summary relative risks
for the association between obesity and liver cancer were 2.15 (95%
CI: 1.66–2.77) for studies based on measured or self-reported
weight and height (Nair et al, 2002; Calle et al, 2003; Batty et al,
2005; Oh et al, 2005; Rapp et al, 2005; N’Kontchou et al, 2006;
Samanic et al, 2006) and 1.61 (95% CI: 1.14–2.27) for studies based
on a discharge diagnosis of obesity (Møller et al, 1994; Wolk et al,
2001; Samanic et al, 2004).
The PAR for excess body weight was calculated using the
estimates of prevalence in the United States (Ogden et al, 2006)
and the obtained summary relative risks of 1.17 and 1.89 for
overweight and obesity, respectively. We estimated that 28% of
liver cancer cases among men and 27% among women could be
attributable to excess body weight (BMIX25kgm
 2).
DISCUSSION
This is the first meta-analysis on overweight and obesity in relation
to liver cancer risk and it indicates that excess body weight is
associated with increased risk. Summary results showed that the
risk was 17 and 89% higher among persons who were overweight
and obese, respectively, compared with those of normal weight.
The relation between obesity and liver cancer seemed to be
stronger in men than in women.
Although there was statistically significant heterogeneity among
study results, the relation between obesity and risk of liver cancer
was consistent. Differences in the relative risk estimates were
largely in the magnitude rather than the direction of the
association. All but 1 out of the 14 relative risk estimates for
the association between obesity and liver cancer were above one
(ranging from 1.44 to 3.76), and 12 of these estimates were
statistically significant.
A potential limitation of this meta-analysis is that individual
studies may have failed to control for potential known or unknown
confounders. The most important risk factors for the development
of liver cancer are chronic infections with hepatitis B virus and
hepatitis C virus. Heavy, long-term alcohol consumption is also a
risk factor (Yu and Yuan, 2004). None of the studies adjusted for
hepatitis B or C virus infections, and only three (Calle et al, 2003;
Kuriyama et al, 2005; Oh et al, 2005) controlled for alcohol intake.
It is unlikely, however, that these risk factors are strongly related
to body weight and entirely explain the observed relationship
between excess body weight and liver cancer risk. Another
limitation is that we could not examine whether the association
between excess body weight and liver cancer was modified by
hepatitis virus infections and alcohol intake because the studies
included in this meta-analysis did not provide results stratified by
these factors.
As this meta-analysis was based on published studies, possible
publication bias could have affected the results. However, neither
funnel plots nor formal statistical tests showed evidence for
publication bias.
The observed increased risk of liver cancer associated with
excess body weight may be mediated through the development of
non-alcoholic fatty liver disease (NAFLD), a chronic liver disease
that occurs in non-drinkers. NAFLD is characterized by a
spectrum of liver tissue changes, ranging from accumulation of
fat in the liver to non-alcoholic steatohepatitis (NASH), cirrhosis,
and liver cancer at the most extreme end of the spectrum. Up to
90% of obese individuals have some degree of fatty liver, and
approximately 25–30% have NASH (Neuschwander-Tetri and
Caldwell, 2003).
Relative risk
0.5 0.7 1.0 1.5 2.0 3.0 4.5 6.0
Relative risk
(95% CI)
Overweight
Calle et al (2003) (M)  1.13 (0.94–1.34)
Calle et al (2003) (W)  1.02 (0.80–1.31)
Kuriyama et al (2005) (M)  0.91 (0.52–1.59)
Kuriyama et al (2005) (W) 1.13 (0.57–2.27)
Batty et al (2005) (M)  0.99 (0.53–1.88)
Oh et al (2005) (M)  1.05 (0.97–1.14)
Rapp et al (2005) (M)  1.32 (0.73–2.37)
N'Kontchou et al (2006) (M/W)  2.00 (1.40–2.70)
Samanic et al (2006) (M)  1.29 (1.00–1.68)
Summary estimate 1.17 (1.02–1.34)
Obesity
Møller et al (1994) (M)  1.90 (1.20–2.90)
Møller et al (1994) (W)  1.90 (1.40–2.70)
Wolk et al (2001) (M) 3.60 (2.00–6.00)
Wolk et al (2001) (W)  1.70 (1.10–2.50)
 Nair et al (2002) (M/W ) 1.65 (1.22–2.22)
Calle et al (2003) (M)  2.41 (1.92–3.01)
Calle et al (2003) (W)  1.47 (1.08–2.00)
Samanic et al (2004) (M, whites)  1.44 (1.28–1.61)
Samanic et al (2004) (M, blacks) 0.68 (0.49–0.94)
Batty et al (2005) (M)  3.76 (1.36–10.4)
Oh et al (2005) (M)  1.56 (1.15–2.12)
Rapp et al (2005) (M)  1.67 (0.75–3.72)
N'Kontchou et al (2006) (M/W) 2.80 (2.00–4.00)
Samanic et al (2006) (M)  3.62 (2.62–5.00)
Summary estimate 1.89 (1.51–2.36)
Figure 1 Relative risks of liver cancer associated with overweight and obesity. Relative risk estimates are for overweight and obese persons compared
with normal weight persons. Tests for heterogeneity: overweight, Q¼16.83, P¼0.03; I
2¼52.5%; obesity, Q¼88.03, Po0.001; I
2¼86.4%. M¼men;
W¼women.
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increased risk of liver cancer among overweight and obese
persons. These findings indicate that liver cancer may, in part,
be prevented by maintaining a healthy body weight.
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